METTL3 and neoplasm: In solid tumors, METTL3-mediated m6A modification of MYC mRNA regulates the stability of the corresponding RNA in urothelial carcinoma [35], prostate carcinoma (PC) [36] and oral squamous cell carcinoma (OSCC) [37], thereby enhancing tumor development.